Compare Edgewise Therapeutics Inc. Common Stock (EWTX) vs Exelon Corporation Common Stock (EXC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edgewise Therapeutics Inc. Common Stock vs Exelon Corporation Common Stock — how do they compare? Edgewise Therapeutics Inc. Common Stock trades at $37.06 (market cap $3.94B), while Exelon Corporation Common Stock trades at $42.82 (market cap $43.61B). The key difference: Exelon Corporation Common Stock is far larger — about 11.1× Edgewise Therapeutics Inc. Common Stock's market cap, and Exelon Corporation Common Stock pays a 3.97% dividend while Edgewise Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals.
| EWTX | EXC | |
|---|---|---|
Market Cap | $3.94B | $43.61B |
Volume | 810,104 | 5,642,975 |
Sector | Health | Utilities |
52-Week High | $48.35 | $50.29 |
52-Week Low | $14.89 | $40.20 |
Typical Hold Time | 0 Days | — |
Enterprise Value | $3.48B | $94.47B |
Dividend Yield | — | 3.97% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Exelon (EXC) trades at $42.34, up 0.52% today, with a mixed technical picture showing a bullish overall signal but bearish moving averages and oscillators. The company reported strong earnings beats in recent quarters except for a Q2 2026 miss, with Q3 2026 results expected on October 30, 2026. Financials show solid profitability with a 10.99% net income margin and a P/E of 15.56, while cash flow trends indicate improving operational performance.
The outlook is cautiously optimistic, supported by a $48.11 analyst consensus price target and institutional accumulation, but risks include regulatory approvals for dividends and high RSI levels suggesting overbought conditions. Earnings growth and grid investment plans are key catalysts, though investor sentiment remains divided amid rate environment uncertainties.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Edgewise Therapeutics Inc. Common Stock
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small-molecule therapies based on its research in muscle physiology, with a pipeline focused on cardiovascular and cardiometabolic conditions such as hypertrophic cardiomyopathy and heart failure.
Read more on EWTX →About Exelon Corporation Common Stock
Exelon is the parent company of six regulated electric and natural gas utilities. Its utilities include Atlantic City Electric, BGE, ComEd, Delmarva Power, PECO, and Pepco.
Read more on EXC →
